MBX Biosciences, Inc. (MBX)
49.55
-3.86
(-7.23%)
USD |
NASDAQ |
Nov 20, 16:00
49.60
+0.05
(+0.10%)
After-Hours: 20:00
MBX Biosciences Cash and Short Term Investments (Annual) : 373.70M for Dec. 31, 2025
Cash and Short Term Investments (Annual) Chart
Historical Cash and Short Term Investments (Annual) Data
| Date | Value |
|---|---|
| December 31, 2025 | 373.70M |
| December 31, 2024 | 262.15M |
| Date | Value |
|---|---|
| December 31, 2023 | 80.68M |
| December 31, 2022 | 42.46M |
Cash and Short Term Investments Definition
Represents the sum of cash and short term investments.
Cash and Short Term Investments (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash and Short Term Investments (Annual) Benchmarks
| Ligand Pharmaceuticals, Inc. | 733.52M |
| Xeris Biopharma Holdings, Inc. | 111.04M |
| ANI Pharmaceuticals, Inc. | 294.75M |
| Corcept Therapeutics, Inc. | 372.15M |
| Veru, Inc. | 18.32M |